Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

US Patent 12048749 · Granted Jul 30, 2024

Estimated economic value: $117,264,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as 2025
Bicyclic heteroaryl compounds and uses thereof2025
Ras inhibitors2025
Ras inhibitors2025
Factor VIII zwitterionic polymer conjugates2025
Ras inhibitors2025
C26-linked rapamycin analogs as mTOR inhibitors2025
C26-linked rapamycin analogs as mTOR inhibitors2025
C26-linked rapamycin analogs as mTOR inhibitors2025
Synthesis of antibacterial aminoglycoside analogs2024
Ras inhibitors2023
Ras inhibitors2023